Podcasts about GE Healthcare

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

Scrappy ABM brings together host Mason Cosby and Yadin Porter de León, Director of Customer Stories and thought leadership over at Heroku, which is a part of Salesforce, to talk about going straight to the top of your target accounts without getting blacklisted.ㅤInstead of getting stuck in email blasts and third-party events that promise “rubbing elbows” with executives, Yadin shares a high-level framework that starts small with relationships your own C-suite already has, then builds proof points through web stories, webinars, podcasts, and thought leadership videos. The conversation walks through going top down from your CEO and bottoms up from directors and senior managers, doing the hard “eat your vegetables” work of segmentation, and mapping LinkedIn so you make it easy for leaders to say yes.ㅤThrough stories from Angel Med Flight, JetBlue, GE Healthcare, NASA Jet Propulsion Labs, Wells Fargo, Michael Dell, and a seven-figure deal, Mason and Yadin show how time and trust, podcasts, and truly helping individuals with their own goals can turn a focused ABM program into a powerful path to the C-suite.ㅤ

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceutical and biotech sectors are currently experiencing a wave of transformative changes. A significant development is the trade agreement between the United States and the United Kingdom, which excludes medicines from import tariffs. This strategic move, orchestrated by the Trump administration, is set to reduce costs and bolster investments in pharma sectors across both nations. By enhancing market accessibility, it aims to stimulate cross-border investment in pharmaceutical research and production.On the clinical front, Eli Lilly is making headlines by joining Novo Nordisk in reducing self-pay prices for its GLP-1 receptor agonist, Zepbound. This reflects a broader industry trend towards patient-centric pricing models aimed at improving affordability. With healthcare costs on the rise, these measures could ease financial burdens for patients requiring long-term medication regimens.Regulatory updates are also making waves, with the FDA planning stricter vaccine regulations under Dr. Vinay Prasad's leadership at the Center for Biologics Evaluation and Research (CBER). These updates come amid concerns over vaccine safety during COVID-19-related incidents, underscoring a commitment to maintaining public trust in vaccines. Regulatory scrutiny continues as Prasad focuses on COVID-19 vaccine safety in children amid reports linking 10 child deaths to vaccines via VAERS—emphasizing challenges interpreting safety data while highlighting the need for robust methodologies ensuring reliable causality conclusions.In corporate restructuring news, Valneva is streamlining its operations by closing a site and eliminating 30 roles. This move highlights an industry focus on optimizing resources to bolster vaccine development pipelines. Meanwhile, Microsize and Schedio's acquisition of Lonza's Swiss micronization plant underscores ongoing investments in advanced manufacturing technologies critical for high-quality pharmaceuticals.In ophthalmology, Belite Bio is advancing with promising Phase 3 results for tinlarebant in treating Stargardt disease—a rare genetic eye disorder. This success positions Belite to file for FDA approval, potentially expanding treatment options for this underserved patient population. Such advancements in targeted therapies emphasize the need for ongoing research in genetic disorders.Regeneron is betting $150 million on Tessera's gene writing technology targeting alpha-1 antitrypsin deficiency (AATD). This collaboration highlights the industry's growing interest in gene therapy as a frontier for treating rare diseases, marking a shift towards precision medicine where tailored genetic interventions offer hope for previously untreatable conditions. Regeneron's strategic move investing $275 million partnering with Tessera exploring gene editing capabilities—focusing on TSRA-196 targeting the SERPINA1 gene linked to AATD showcases potential advancing therapeutic options for genetic disorders through gene editing technologies offering new disease treatment avenues.AI-driven platforms were spotlighted at RSNA 2025 by industry leaders such as GE Healthcare, Philips, and Siemens. These innovations promise to revolutionize radiological workflows by enhancing diagnostic accuracy and operational efficiency through AI integration. As AI continues to permeate healthcare technologies, its potential to transform diagnostic processes marks a significant leap towards personalized medicine.Akebia Therapeutics' acquisition ofSupport the show

This week, we're diving into a flurry of major M&A activity from GE's $2.3B healthcare tech acquisition to Violia's $3B hazardous waste deal and a massive offshore wind farm stake sale by Denmark's Ørsted. But the spotlight is on Warner Bros. Discovery, where a high-stakes bidding war is heating up.With Paramount, Netflix, and Comcast all circling, Anthony and Piers unpack why the media giant rejected multiple multi-billion dollar offers and how strategic tension is being used to push up valuations. Is splitting the company more valuable than selling it whole? And what's the endgame for each suitor?(00:00) Rate Cut Hopes & Market Moves(07:34) M&A Roundup: Paint, Healthcare & Waste(10:27) Wind Power Play: Ørsted & Apollo(12:39) Warner Bros vs Paramount(24:34) Netflix & Comcast Join the Fray(32:00) Who Buys the Crown Jewels

Send us a textFew people enter the MedTech world because of a personal experience with the technology itself—but for Brent Lavin, that's exactly where it began. At just 23 years old, a CT scan that revealed an urgent medical issue also sparked a lifelong passion for medical technology and its power to save lives. That moment became the foundation of a career devoted to driving innovation in healthcare.Brent's early engineering work revealed an exceptional talent for connecting technical possibility with human need. Over the next two decades, he would lead cross-functional teams through more than 20 successful product launches, three mergers and acquisitions, and hundreds of millions of dollars in portfolio growth. His leadership—marked by curiosity, clarity, and conviction—has earned him accolades such as BD's Director of the Year and the CEO Excellence Award.Today, as Director of Strategic Growth at BD, Brent is responsible for identifying high-impact opportunities for both organic development and targeted acquisitions. Previously, he served as Director of Marketing and Product Management, where he led global teams across multiple disease states to record-breaking revenue growth, even in the face of pandemic-era supply chain challenges.Before joining BD, Brent spent years at GE Healthcare, where he honed his product management and global commercialization expertise, launching next-generation ultrasound systems that achieved over 200% year-over-year growth. His career reflects a rare blend of technical grounding, marketing strategy, and human-centered leadership—built on a mission to deliver meaningful innovation to clinicians and patients worldwide.Beyond the numbers, Brent is known for building high-performing teams and mentoring leaders who thrive in complex environments. Whether he's shaping go-to-market strategies, integrating newly acquired companies, or guiding engineers toward greater clarity and impact, his approach is grounded in purpose: to help people and teams reach their full potential while bringing life-changing technologies to market. LINKS:Guest LinkedIn: https://www.linkedin.com/in/brent-lavin/ Aaron Moncur, hostDownload the Essential Guide to Designing Test Fixtures: https://pipelinemedialab.beehiiv.com/test-fixtureAbout Being An Engineer The Being An Engineer podcast is a repository for industry knowledge and a tool through which engineers learn about and connect with relevant companies, technologies, people resources, and opportunities. We feature successful mechanical engineers and interview engineers who are passionate about their work and who made a great impact on the engineering community. The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us

O'Hare air traffic has finally topped pre-pandemic levels and appears on track to break a record this year. Crain's aviation reporter John Pletz discusses with host Amy Guth.Plus: One of downtown's biggest distressed loans goes up for sale, Chicago Fed's Goolsbee says he's uneasy about "front loading" rate cuts, GE HealthCare to buy Intelerad for $2.3 billion in cash and feds accuse Chicago crypto firm and its CEO of laundering $10 million. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Nvidia, Paramount, Comcast, Netflix, Meta, GAP y GE Healthcare son los protagonistas. Lo analizamos con Ricardo Tomás, asesor del fondo Multigestión Basalto USA.

Send us a textThijs Spoor is Chief Executive Officer at Perspective Therapeutics ( https://perspectivetherapeutics.com/ ), a clinical-stage, radiopharmaceutical company that is pioneering innovative treatments for cancers. The Company's proprietary technology utilizes the alpha emitting isotope Pb-212 to deliver powerful radiation directly to cancer cells via high-affinity targeting peptides.Prior to this, Thijs was the Chairman at Verifi H2O. Thijs also held the position of Chief Executive Officer at Viewpoint Molecular Targeting, Inc. and KBP BioSciences.Thijs also has served as CEO at AzurRx BioPharma, where they focused on developing targeted therapies for gastrointestinal diseases, and CEO at FluoroPharma, a company focused on the discovery, development, and commercialization novel molecular positron emission tomography (PET) agents for the cardiovascular, oncology and neurology arenas.Thijs also worked as a Strategy Consultant at Oliver Wyman, a Biotechnology Analyst at J.P. Morgan, and a Medical Devices Analyst at Credit Suisse. Thijs began their career at GE Healthcare, where he served as the Director of Strategic Marketing and played a key role in reshaping the company's strategic directions in various areas.Thijs completed his Bachelor of Science in Pharmacy from the University of Toronto and an MBA in Finance from Columbia Business School.#ThijsSpoor #PerspectiveTherapeutics #Radiopharmaceuticals #NuclearMedicine #Cancer #Oncology #AlphaEmittingIsotopes #AlphaParticles #BetaParticles #Radiation #Lead #Pb212 #Lutetium #Actinium #CellTargetingPeptide #Chelator #Linker #NeuroendocrineTumors #SomatostatinReceptorSubtype2 #Melanoma #Theranostic #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textIn the final episode of our Rethinking Phototherapy series, Ben speaks with Steve Falk, Chief Engineer of the Maternal Infant Care Strategic Business Unit at GE Healthcare. With more than three decades of engineering leadership, Steve has been instrumental in the development of landmark neonatal technologies, including the Giraffe Omnibed and Panda platforms.This conversation highlights the critical role of engineering in making phototherapy precise, reliable, and safe. Steve explains how advances in LED technology have transformed phototherapy devices, ensuring consistent irradiance and long product life. He describes how engineers translate clinical needs—wavelength, intensity, surface coverage, and distance—into product requirements, and how rigorous usability testing with clinicians shapes intuitive bedside tools. The discussion also explores innovation on the horizon, from refining intermittent phototherapy strategies to integrating technologies that simplify care and support earlier discharge.Listeners will gain a behind-the-scenes perspective on how engineering teams think about phototherapy as a true pharmacotherapy, and how collaboration between clinicians and industry can directly improve outcomes for newborns and families. This episode closes the series by reminding us that innovation in neonatal care happens not only in clinical practice, but also in the design labs where these essential tools are created.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Trust is the foundation for successfully integrating AI into healthcare systems. In this episode, Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE Healthcare, shares how AI is transforming operational efficiency, clinical workflows, and patient outcomes across health systems. He highlights applications such as ambient AI for documentation, AI-driven hospital operations, and unified data infrastructures that ease clinicians' cognitive load. Through GE Healthcare's CareIntellect platform and collaborations with systems like HCA, Duke Health, and Queen's Health, hospitals have achieved measurable improvements, including a 22% boost in patient transfers and $20 million in savings. Dr. Kass-Hout also emphasizes the importance of trust, interoperability, and clinician co-design to ensure AI adoption is ethical, scalable, and effective. Tune in and learn how AI-powered infrastructure and trust-driven innovation are redefining the future of healthcare delivery! Resources Connect with and follow Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and explore their website! Listen to Taha's previous episode on the podcast here Browse the GE Healthcare Research website.

if you have any feedback, please send us a text! Thank you!Dr. J.W. Beard, a UCSF-trained anesthesiologist and Chief Medical Officer of GE Healthcare's Patient Care Solutions division, joins the Vital Times podcast to discuss his remarkable career journey. As a member of the Board of the Anesthesia Patient Safety Foundation, Dr. Beard shares how his background in anesthesiology uniquely prepared him for leadership in the medical technology industry, and offers insights into bridging clinical practice and innovation. 

Max Milz is Group Vice President Connected Technology Solutions at Dentsply Sirona, leading its digital healthcare portfolio, which includes imaging, CAD/CAM, surgical equipment, and AI-based clinical software. A passionate tech leader, he previously spent 12 years at Siemens AG, including five years in China. He serves on the Advisory Board of the Value for Good Foundation and holds degrees from Harvard and Cambridge.   David Ferguson joined Dentsply Sirona as Senior Vice President, Global Business Units in March 2025. David Ferguson is a seasoned executive with extensive leadership experience in the medical device and healthcare industries. He has a strong track record of driving revenue growth, strategic transformation, and operational excellence across multiple global businesses. Most recently, he was President of Gore Medical, a unit of W.L. Gore. Previously, as EVP at Philips and President & CEO of Philips Respironics, he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions and patient monitoring business. He also held leadership roles at GE Healthcare. Mr. Ferguson is a Graduate of the Advanced Management Program of University of Chicago Booth School of Business and holds a PhD in Chemistry from Texas A&M University and Bachelor of Science in Biochemistry from David Lipscomb University. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation, and is a co-inventor of two U.S. patents and author of ten peer-reviewed publications.

In this episode of The Lebanese Physicians Podcast, co-hosts Dr. Khalil Diab and Dr. Hamad Ali sit down with Dr. Firas Mahdi, Partner at LEK Consulting in Singapore, to explore the intersection of strategy, technology, and innovation in healthcare across Asia and the Middle East. From his beginnings in clinical medicine at AUBMC to leadership roles at GE Healthcare, Medtronic, and now LEK, Dr. Mahdi shares a remarkable global journey spanning Lebanon, the Gulf, and Southeast Asia. We discuss: How Singapore's hybrid public–private healthcare model achieves world-class outcomes Lessons for Middle Eastern health systems in value-based care and operational excellence The evolving role of MedTech and AI in shaping the future of healthcare Building purpose-driven careers and navigating non-clinical paths in medicine A rich conversation about healthcare transformation, professional reinvention, and the future of global health strategy — where East truly meets Middle East.  

In this episode of The Dish on Health IT, host Tony Schueth, CEO of Point-of-Care Partners (POCP), is joined by colleagues Brian Dwyer, POCP's Business Strategy Lead, and Seth Joseph, Managing Director at Summit Health Advisors, to unpack their takeaways from the HLTH25 conference in Las Vegas. Together, they reflect on the energy of the event, the conversations shaping the future of health IT, and interviews recorded live from Podcast Row.The trio kicks off by comparing notes on how HLTH has evolved from a flashy innovation show to something more grounded, a space where serious conversations about interoperability, investment, and operational impact are starting to take hold. Seth notes the event's “coming-of-age” moment, where hype gave way to maturity. Brian agrees, adding that the buzz of startups pitching and investors circling was balanced by a sense of realism about implementation and outcomes.AI dominated every conversation, but with a more pragmatic tone than in years past. The hosts discuss how AI is shifting from novelty to necessity, moving from “AI for AI's sake” to purpose-driven use cases. Interview clips from leaders like Taha Kass-Hout with GE Healthcare spotlight “agentic AI,” where autonomous systems could act as trusted colleagues in care delivery, even participating in tumor board decisions to help extend expertise to rural or underserved regions. The group connects this to the ongoing challenge of ensuring data quality and interoperability as the foundation for any AI success story.Laurie McGraw of Transcarent and Kyle Kiser of Arrive Health bring different but complementary perspectives. Laurie underscores AI's potential to bend the cost curve only if applied safely and effectively, while Kyle highlights the growing complexity of affordability and the need for intelligent systems to help patients and providers navigate fragmented benefits and prescription pricing. Seth and Brian note that the shift toward patient empowerment, fueled by AI and transparency, could signal a broader cultural change in healthcare where consumers wield more influence.The discussion expands into value-based care with insights from McKesson's John Beardsley, who questions whether the industry has truly cracked the code after two decades of running at value-based care and interoperability. John also raises an important tension: small innovators are doing exciting things with AI, but scaling those solutions across full workflows remains the real test. The hosts debate whether new payment models, potentially powered by AI-driven insights, could finally make value-based care viable.Policy and regulation also take center stage as Christopher Chen, MD, MBA, Chief Medical Officer at the Washington State Health Care Authority, shares how state and federal efforts are aligning to accelerate interoperability, reduce provider burden, and modernize prior authorization processes under CMS-0057. The hosts reflect on the importance of federal leadership to align incentives across payers, providers, and technology vendors, echoing lessons learned from the early days of ePrescribing.Other memorable interview moments include John Beardsley's commentary on the CMS Interoperability and Patient App Pledges and how better understanding how NCPDP and FHIR standards bridge pharmacy and clinical data silos could help move the needle. Brian and Seth build on that theme, envisioning a future where agentic AI and patient-facing apps work together to drive true engagement and accountability for health outcomes.In the final stretch, the hosts revisit recurring topics such as physician burnout, administrative burden, and structured data chaos, tying them back to the industry's broader need for smarter implementation and aligned incentives. From Christopher Chen's relaying an anecdote about seeing structured data turned into unreadable images that are faxed in to Arrive Health's use of AI to prevent unnecessary transactions, the episode surfaces a consistent theme: technology alone won't fix healthcare, but when paired with aligned incentives, collaboration, and business transformation, it can finally make measurable progress.The episode closes with optimism. Tony, Brian, and Seth agree that while the system is strained, it's also full of momentum, from maturing AI applications to government action and renewed industry alignment. As Tony puts it, “There's a lot to be hopeful about and a lot of work left to do.”Listen to the full episode to hear interviews from the HLTH25 floor, including thought leaders discussing interoperability, agentic AI, and the real-world changes needed to make healthcare innovation stick.Share The Dish on Health IT from Spotify, Apple Podcasts, or Healthcare NOW Radio, Watch extended clips on the POCP YouTube channel

In this episode of the Org Design Podcast, host Tim Brewer and guest cohost Rory Mustan sit down with John Deverill—former British Army lieutenant colonel, ex-GE Healthcare leader, and current NHS change-maker. John shares how the disciplines of military leadership translate into organizational agility, what healthcare can learn from the battlefield, and why most organizations evolve by accident rather than intentional design. From rethinking strategy as “what you actually do,” to building coalitions of the willing, to balancing tradition with innovation, John delivers a masterclass on leading through uncertainty. Whether you're running a hospital, a corporation, or a fast-growing team, this episode will challenge how you think about leadership, strategy, and organizational resilience. John Deverill - https://www.linkedin.com/in/john-deverill-a04a7b1 EODF - https://eodf.eu/ Functionly https://www.linkedin.com/company/functionly https://www.functionly.com/ Org Design Podcast https://www.linkedin.com/company/orgdesignpodcast https://www.functionly.com/org-design-podcast

HR Works Podcast: GE Healthcare on Healing Your People Strategy by HR Daily Advisor

What does it really take to become lean—not just do lean?This is the secret to transformational lean leadership that Larry Culp, CEO of GE and GE Aerospace shared with me on stage three years ago. In this special bonus episode, I want to share his insights and wisdom about leadership and lean culture with you.This bonus episode marks two milestones in my own Chain of Learning® journey: 

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh welcomes Mark Kramer, the founding director of FDA's Office of Combination Products (OCP). Mark takes us on a deep dive into the history of how combination products have been regulated in the U.S., starting with the Safe Medical Devices Act of 1990 and how the process evolved into the formation of OCP in 2002.We explore questions such as: What challenges did industry and the FDA face in the early days of combination products? How did the “Request for Designation” process come about, and how is regulatory identity determined? What is the “Primary Mode of Action” (PMOA) rule and why does it matter? How do user fees, cross-center coordination, and post-market regulations shape how combination products get to market and are monitored? Mark also highlights current regulatory gapssuch as cross-labeling and site registration issues that continue to impact developers.Whether you're working in med-tech, pharma, or regulatory affairs, this episode offers historical perspective, technical insights, and strategic take-aways for navigating the combination-product space. Tune in for a candid conversation with one of the leading figures in this field.Timestamps:00:00 Introduction & Guest Welcome00:35 Historical Background of Combination Products03:05 Creation of Office of Combination Products (OCP)04:29 Early Challenges and Developments04:54 MDUFA, PDUFA, User Fee Programs & Legislative Impact14:24 Defining Primary Mode of Action (PMOA)18:35 OCP's Role & Responsibilities26:49 Industry Adoption & Challenges38:48 Regulatory Gaps & Future Directions46:00 Conclusion & Contact InformationContact & Resources:Connect with Mark Kramer on LinkedIn or via email at Mark.Kramer@greenleafhealth.comMark Kramer is Principal of the Medical Devices & Combination Products regulatory practice at Eliquent Life Sciences (formerly Greenleaf Health). He has more than 35 years experience at FDA and in regulated industry. At FDA, he established and directed the Office of Combination Products and was a scientific reviewer and later supervisor of the premarket review of devices in a variety of medical discipline areas. Following his FDA career, he served as Regulatory Affairs Executive and Chief Regulatory Strategist at GE Healthcare and then as an independent regulatory consultant for over 10 years before joining Greenleaf. Mark served as a board member of the Regulatory Affairs Professionals Society (RAPS) and in 2021, he was awarded the RAPS Founders Award, the profession's highest honor, recognizing exemplary regulatory professionals who have shaped regulatory policy and practice and have made a positive impact on the profession.Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

Crain's residential real estate reporter Dennis Rodkin joins host Amy Guth to talk news from the local housing market, including Chicago's narrowing lead over U.S. home price growth.Plus: Fed cuts rates quarter point, sets end to balance-sheet runoff, GE HealthCare takes $100 million hit from tariffs, Kraft Heinz lowers sales outlook as CEO warns of worst consumer sentiment in decades and Mondelez also trims outlook, and a developer gets $94 million construction loan for the first phase of its Motorola campus remake.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

market-moving events. The spotlight is on tech with earnings from heavyweights like Microsoft, Google, Meta, and ServiceNow set to hit after the bell. The Fed announcement and Chair Powell's press conference are front and center today, followed by U.S.–China trade talks at tomorrow's APEC Summit. Markets are leaning into a positive narrative—particularly across the tech sector—while energy, healthcare, and materials trail behind. We'll break down the earnings movers, from CAT and GE Healthcare to CVS and Visa, and what all this means for the market's next move.

Die Rallye setzt sich fort, angefacht durch solide Ergebnisse. Außerdem signalisiert Donald Trump, dass die wegen Fentanyl etablierten 20%-Zölle gegen China halbiert oder abgeschafft werden dürften. Trump betont ebenfalls, dass in den Gesprächen mit Xi auch NVIDIA ein Thema sein wird. An der Wall Street werden die Ziele für die Aktie weiter angehoben, unter anderem von der Bank of America und der UBS. Mit der Bewertung nun bei bereits $5 Billionen, betont CEO Jensen Huang, dass es sich in dem Sektor um keine Spekulationsblase handeln soll. Die Ergebnisse aus dem Tech-Sektor fallen seit gestern Abend solide aus, mit robusten Zahlen von SK Hynix, Seagate, Teradyne und Bloom. Nach dem Closing melden Google, Meta und Microsoft Ergebnisse. Man wird sich vor allem auf die Capex-Investitionen fokussieren. Auch außerhalb des Tech-Sektors fallen die Zahlen robust aus, mit den Aktien von Booking Holdings, CVS Health, Caterpillar, GE Healthcare, und Verizon teils stärker im Plus. Visa und Mondelez stehen nach den Quartalszahlen leicht unter Druck. Etsy verliert rund 10% vor Handelsstart. Dort wird unter anderem der CEO ausgetauscht. Um 20 Uhr MEZ wird die US-Notenbank den Leitzins um 25 Basispunkte senken. Die Wall Street vermutet, dass auch das Ende des Abbaus der Bilanz gemeldet wird. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Die Rallye setzt sich fort, angefacht durch solide Ergebnisse. Außerdem signalisiert Donald Trump, dass die wegen Fentanyl etablierten 20%-Zölle gegen China halbiert oder abgeschafft werden dürften. Trump betont ebenfalls, dass in den Gesprächen mit Xi auch NVIDIA ein Thema sein wird. An der Wall Street werden die Ziele für die Aktie weiter angehoben, unter anderem von der Bank of America und der UBS. Mit der Bewertung nun bei bereits $5 Billionen, betont CEO Jensen Huang, dass es sich in dem Sektor um keine Spekulationsblase handeln soll. Die Ergebnisse aus dem Tech-Sektor fallen seit gestern Abend solide aus, mit robusten Zahlen von SK Hynix, Seagate, Teradyne und Bloom. Nach dem Closing melden Google, Meta und Microsoft Ergebnisse. Man wird sich vor allem auf die Capex-Investitionen fokussieren. Auch außerhalb des Tech-Sektors fallen die Zahlen robust aus, mit den Aktien von Booking Holdings, CVS Health, Caterpillar, GE Healthcare, und Verizon teils stärker im Plus. Visa und Mondelez stehen nach den Quartalszahlen leicht unter Druck. Etsy verliert rund 10% vor Handelsstart. Dort wird unter anderem der CEO ausgetauscht. Um 20 Uhr MEZ wird die US-Notenbank den Leitzins um 25 Basispunkte senken. Die Wall Street vermutet, dass auch das Ende des Abbaus der Bilanz gemeldet wird. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

In this episode, Hemish was joined by Karin von Hodenberg, VP of Quality at Monte Rosa Therapeutics.Karin has repeatedly built quality systems from the ground up across med device and biotech, and she translates that experience into practical, phase-appropriate guidance for early teams.Karin's journey is anything but typical: a business background, supply chain and Lean Six Sigma Black Belt training led her into quality at GE Healthcare and Philips, before moving into biotech with bluebird bio during rapid growth. She's since led in several startups and now at Monte Rosa, where she's implemented validated systems early and embedded a genuine culture of quality across GxP.She talks about the following:Why a non-traditional path (business → supply chain → Six Sigma) can be a superpower in Quality.From paper to validated eQMS: how bluebird bio migrated training & documents and why they verified 100% of records.Trigger points for moving beyond paper: signs you're outgrowing a doc control room and how to stand up DMS/LMS/LIMS early.Phase-appropriate, risk-based thinking: using data, science and regulations - without becoming a blocker.Making quality ‘cool': education, storytelling, and visible sponsorship from ELT.Leading without fear: replacing “inspection readiness day” with “inspection readiness every day.”Critical thinking over checkbox compliance: hiring, interview questions, and building the muscle across teams.Working with functional heads: cadence of 1:1s, being a partner (not a gate), and influencing through solutions.Roadmaps that breathe: Karin's 3‑year plan, quarterly outcomes, and how transparency sustains engagement in uncertainty.AI pragmatism in quality: where note-taking and drafting help now - and where human judgment still rules.Karin is a thoughtful, pragmatic Quality leader who balances compliance with business value - bringing people with her as she builds systems that last.Thank you Karin for sharing your incredible journey.Hope everyone enjoys the show!

In this episode, Jan Beger, Global Head of AI Advocacy at GE Healthcare, shares his mission to bridge the gap between the conceptual promise and real-world impact of AI in healthcare. He stresses on the critical need to build AI literacy and trust among clinicians, executives, and students, and explains why a human-centric approach and strong change management are critical for successful adoption. Jan highlights GE's global AI literacy programs that train employees and clinicians on responsible use, practical applications, and critical evaluation of AI. He highlights how moving beyond pilots to strategic, systemwide deployment requires continuous education, executive engagement, and a focus on change management. He also spoke about GE's successes such as improved efficiency in software development and innovations like AI-guided handheld ultrasound devices that democratize imaging by supporting users of varied expertise, as well as the challenges of keeping AI tools robust and up-to-date. Jan addresses the future of the workforce, noting that adaptability and tech fluency will be essential as 70% of job skills evolve by 2030. He encourages healthcare leaders to see AI not just as technology, but as a transformative tool to enhance care and outcomes. Take a listen.

India has long held its position as the “pharmacy of the world” and a global biotech hub. And now, another revolution is unfolding in medical technology with India aiming to become a $30 billion MedTech manufacturing powerhouse by 2030. Leading this from the forefront is Wipro GE Healthcare, which is building products not just for India but also for the world. The company has 1200+ patents and is revolutionising healthcare by improving accessibility and affordability. With 4 world-class manufacturing sites, listen in to know how it is contributing towards India's sunrise sector - MedTech.

In this episode of the WLEI Podcast, we speak with Eric Ethington and Matt Zayko about how to build strong teams and robust product and process development systems, and why doing so takes a skilled chief engineer. Eric Ethington is a senior coach and Chief Engineer, Lean Product and Process Development (LPPD) at The Lean Enterprise Institute. Matt Zayko is global head of the Lean Office at GE HealthCare. Eric and Matt are also coauthors of the book, The Power of Process: A Story of Innovative Lean Process Development.   The conversation explores:   The key skills every chief engineer needs to be effective and “lead with responsibility, not authority”   How chief engineers can begin the work of “designing the value stream”  Why conflict is necessary to create good products and how to manage conflict with care   System integration and how chief engineers optimize work at the product level, balancing the inputs and needs of product development and manufacturing, for example  Real stories of product and process development where Eric and Matt have seen teams persevere and use LPPD thinking to innovate and achieve success     Read Eric and Matt's article “9 Tips to Better Process Development” here.    Get Started with Lean Product & Process Development  Improving how you develop and deliver products doesn't require a full transformation to start—it begins with learning to see problems clearly, involve your team, and improve how work gets done.  Explore your next step:  Read Designing the Future or The Power of Process  Take the 60-minute Lean Product and Process Development Overview course  Join the coach-led online Designing the Future Workshop for hands-on practice, and the in-person Introduction to Lean Process Development course Oct 7  Bring a coach into your organization for customized support  Let's take the first step—together. Learn more at lean.org/LPPD » 

Dr. Linda Chu speaks with Dr. Andrew Trout, Professor of Radiology and Director of Clinical Research at Cincinnati Children's, and Dr. Erin Angel, Vice President of Research and Scientific Affairs at GE HealthCare. They discuss the unique challenges of pediatric imaging and how collaboration and technology are advancing care for young patients while improving imaging for all. Sponsored by GE HealthCare.

In this episode of the HR Leaders Podcast, we speak with Adam Holton, Chief People Officer at GE HealthCare, about the mindset shifts HR leaders need to harness AI, personalize learning, and lead with authenticity. Adam explains why example matters more than instruction, why democratized learning is changing leadership, and how AI can act like a “superpower” for HR teams. The conversation covers embedding AI into coaching, rethinking processes instead of just automating them, and creating sticky adoption through daily use cases.

Get the book!The greatest innovations often begin with a simple question: "What if we tried this differently?" In this fascinating exploration of innovation mindsets, we unpack the two complementary approaches that fuel breakthroughs—design thinking and first principles thinking.hese very approaches are at the heart of my book Protection for the Inventive Mind, a practical fieldbook that helps inventors and creatives turn frustrations into prototypes and big ideas into protected strategies.From the Wright brothers' wind tunnel experiments at Kitty Hawk to SpaceX landing rockets upright, we trace how returning to fundamental truths allows inventors to rebuild solutions from scratch. These stories show first principles thinking as the "logic scalpel" that cuts through assumptions and tradition to reveal new possibilities.Alongside this analytical approach, we discover design thinking—the "empathy engine" that powers human-centered innovation. We see how watching an arthritic woman struggle with kitchen tools birthed OXO Good Grips, how children's tears transformed hospital MRI machines into pirate ships, and how PillPack revolutionized medication management by truly understanding patient frustrations.The episode reveals surprising connections between seemingly unrelated innovations. The kingfisher bird's perfect dive inspired Japan's bullet train nose design. Velcro emerged when a Swiss engineer examined burrs stuck to his dog under a microscope. These moments of biomimicry demonstrate how nature offers solutions to our most persistent challenges.What's particularly inspiring is how often world-changing ideas emerge from everyday annoyances—James Dyson's 5,000 vacuum prototypes, IKEA's flat-pack revelation from a stubborn table that wouldn't fit in a car, and Airbnb's humble beginnings with air mattresses on an apartment floor. These stories prove that frustration can be billion-dollar inspiration when viewed through the right lens.Ready to apply these mindsets to your own challenges? Listen for five actionable innovation principles distilled from these remarkable stories, and discover how combining empathy with fundamental thinking can transform not just products, but experiences, systems, and culture itself. Whether you're sketching on a napkin or aiming for the stars, the way you think might be your greatest invention yet.Send us a textSupport the show

What does it take to build intelligent systems that are not only AI-powered but also secure, scalable, and grounded in real-world needs? In this episode of Tech Talks Daily, I speak with Srinivas Chippagiri, a senior technology leader and author of Building Intelligent Systems with AI and Cloud Technologies. With over a decade of experience spanning Wipro, GE Healthcare, Siemens, and now Tableau at Salesforce, Srinivas offers a practical view into how AI and cloud infrastructure are evolving together. We explore how AI is changing cloud-native development through predictive maintenance, automated DevOps pipelines, and developer co-pilots. But this is not just about technology. Srinivas highlights why responsible AI needs to be part of every system design, sharing examples from his own research into anomaly detection, fuzzy logic, and explainable models that support trust in regulated industries. The conversation also covers the rise of hybrid and edge computing, the real challenges of data fragmentation and compute costs, and how teams are adapting with new skills like prompt engineering and model observability. Srinivas gives a thoughtful view on what ethical AI deployment looks like in practice, from bias audits to AI governance boards. For those looking to break into this space, his advice is refreshingly clear. Start with small, end-to-end projects. Learn by doing. Contribute to open-source communities. And stay curious. Whether you're scaling AI systems, building a career in cloud tech, or just trying to keep pace with fast-moving trends, this episode offers a grounded and insightful guide to where things are heading next. Srinivas's book is available on Amazon under Building Intelligent Systems with AI and Cloud Technologies, and you can connect with him on LinkedIn to continue the conversation.

Send us a textJoin us for an in-depth conversation with Bryant Foster, a human factors expert who's worked with industry giants like Google to make complex products simpler and safer. With a background in cognitive psychology, Bryant shares insights on designing user-friendly products, from surgical systems to smart thermostats, all while keeping the end user at the center of the design process.Main Topics:What drew Bryant into human factors and user experience designHow to define and achieve simplicity in product designAdvanced usability testing tools: eye tracking, pupilometry, and facial emotion analysisWhy users don't always give honest feedback and how to work around itProviding critical design feedback without demoralizing teamsCost-effective approaches to human factors testingSafety considerations in medical device designUse-related risk analysis and task analysis methodologiesLessons learned from working at Google XBuilding successful human factors consulting teamsAbout the guest: Bryant Foster is the Vice President of Human Factors and User Experience at Research Collective, a user-centered research consultancy serving clients from startups to major companies like GE Healthcare, Microsoft, and Medtronic. With over a decade of experience in applied psychology and usability research, he specializes in ensuring products are safe, intuitive, and user-focused.He holds a Master's in Applied Psychology (Human Factors) from Arizona State University and began his career at the Cognitive Engineering Research Institute, later working at Google X as a UX researcher. At Research Collective in Tempe, Arizona, he leads a team that uses methods like ethnography, eye tracking, and biometric analysis.In addition to his consulting work, Bryant mentors students and supports local entrepreneurs through programs like LEAP, blending scientific rigor with empathy in fields from medical devices to consumer tech.Links:Bryant Foster LinkedInResearch Collective WebsiteClick here to learn more about simulation solutions from Simutech Group.

In this industry sponsored episode, host Praveen Ranganath speaks with Dr. Seth Uretsky from Morristown Medical Center about the growth of their multimodality cardiac imaging program. Tune in and enjoy!This episode is sponsored by GE HealthCare.References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

In this episode, we explore how nonprofit organizations like LBDA are working alongside industry partners to shape the evolving landscape of dementia biomarkers—bridging scientific innovation with real-world care. Featuring an engaging conversation with Dr. Sudhir Sivakumaran, Dr. Kathleen Poston, and Dr. Dustin Dunham on clinical utility, patient-centered research, and the road to broader adoption of biomarkers in Lewy body dementia, Alzheimer's disease and related disorders. This episode is sponsored by GE HealthCare

European bourses are mixed amidst a slew of earnings, US futures flat/firmer ahead of a busy data docket and earnings from Meta and Microsoft.USD rally pauses for breath as markets await Q2 flash GDP and FOMC.USTs contained into numerous US events, Bunds were little moved by national and EZ-wide GDP metrics.Crude takes a breather after Tuesday's rally while gold holds around the unchanged mark.Looking ahead, US ADP National Employment, GDP Advance (Q2), PCE (Q2), Fed, BoC, BCB Policy Announcements Speakers including Fed Chair Powell, BoC's Macklem & Rogers. US Quarterly Treasury Refunding Announcement.Earnings from Airbus, Vinci, Microsoft, RobinHood, Carvana, Lam Research, Qualcomm, Ford, Arm, eBay, FMC, Vertiv, Altria, Kraft Heinz, GE Healthcare.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

US Treasury Secretary Bessent said he will see US President Trump regarding the China tariff pause on Wednesday and some technical details remain on the China tariff pause, while the China tariff extension decision will be up to Trump and if he does not approve tariff pause extension, tariffs on Chinese goods would 'boomerang' back to April 2nd levels, or another level that he chooses.US President Trump said Chinese President Xi wants to meet and he thinks it will happen before the end of the year, while he stated that they will either approve the trade extension or not. Chinese Vice Commerce Minister Li said the US and China have agreed to extend the trade truce; Bessent said China jumped the gun a little on the 90-day pause.Crude futures surged yesterday amid comments from US President Trump who confirmed changing the deadline for Russia to reach a Ukraine ceasefire agreement to 10 days, while there were simultaneous comments from Treasury Secretary Bessent who told Chinese officials that China could face high tariffs if it continues to purchase sanctioned Russian oil due to US secondary tariff legislation.APAC stocks traded mixed following the subdued handover from Wall St; European equity futures indicate a mildly positive cash market open with Euro Stoxx 50 futures up 0.3% after the cash market closed with gains of 0.8% on Tuesday.Looking ahead, highlights include French GDP, Spanish CPI, German GDP & Retail Sales, Italian GDP, ECB Wage Tracker, EZ GDP & Sentiment, US ADP National Employment, GDP Advance (Q2), PCE (Q2), Fed, BoC, BCB Policy Announcements Speakers including Fed Chair Powell, BoC's Macklem & Rogers, Supply from Italy, US Quarterly Treasury Refunding Announcement.Earnings from Hermes, Airbus, Vinci, Danone, Capgemini, HSBC, GSK, Aston Martin, Santander, Caixabank, Telefonica, Intesa Sanpaolo, Leonardo, Mercedes Benz, Siemens Healthineers, BASF, Adidas, Porsche AG, Meta, Microsoft, RobinHood, Carvana, Lam Research, Qualcomm, Ford, Arm, eBay, FMC, Vertiv, Altria, Kraft Heinz, GE Healthcare & VF Corp.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

U.S. stocks are hitting all-time highs, but can the rally continue? According to Adam Johnson, portfolio manager of the Bullseye American Ingenuity Fund, the answer is a resounding yes. In this high-energy interview, Adam makes the bullish case for American innovation, explains why AI is the most transformative force of our time, and names the companies poised to dominate the next decade. From autonomous trucking and warehouse robotics to Tesla's humanoid factory workers, Adam reveals the real-world AI applications already disrupting industries—and how investors can position for it. He also shares how he manages risk, takes profits, and navigates volatility in a market full of mixed signals.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Cristian: Curiosity and passion.The danger of radiation exposure has always been a concern in medical imaging, especially in surgeries requiring 3D visualization. Cristian Atria, Founder & CEO of nView medical, has tackled this challenge head-on with groundbreaking technology that reduces radiation exposure while improving surgical outcomes.In this interview, Cristian explained how nView's innovative surgical scanner allows surgeons to see in 3D during operations, creating images in seconds without the risks associated with traditional imaging methods like CT scans. “We've created a new way to create images very fast in 3D,” Cristian shared. “The surgeon has the benefit of having 3D visualization, which leads to more accurate surgeries without the cost of having to radiate the patient.”This cutting-edge technology is already making an impact, particularly in pediatric surgeries. Cristian emphasized the importance of protecting children, who are especially vulnerable to radiation, while ensuring surgeons have the tools they need for complex procedures. “We decided to start in pediatrics first because it's the population that requires more protection with respect to radiation,” he explained.What makes this innovation even more compelling is that it isn't just a prototype or a distant dream. nView's devices are already being used clinically, and the company is now raising capital via a regulated crowdfunding campaign on StartEngine. This campaign provides an opportunity for ordinary investors to support—and benefit from—this life-changing technology.Cristian's work highlights the potential of innovation to improve not just health outcomes, but also the quality of care for vulnerable populations. By reducing risks and enhancing surgical precision, nView medical is reshaping the future of healthcare.For those intrigued by the potential of this technology, the crowdfunding campaign offers a chance to be part of this transformative journey. As Cristian noted, “This is a technology we've developed over the last 10 years, and it's already being used clinically.”This is exactly the kind of innovation that deserves attention and support.tl;dr:Cristian Atria's nView medical developed technology for fast, low-radiation 3D imaging during surgeries.The technology improves surgical precision, especially in pediatric procedures, reducing risks for vulnerable patients.nView's devices are commercially available, and the company is raising funds via StartEngine crowdfunding.Cristian's superpower, curiosity and passion, drives his success in solving complex problems innovatively.A personal story of saving his son's life illustrates the power of persistence and asking questions.How to Develop Curiosity and Passion As a SuperpowerDuring today's episode, Cristian revealed his superpower: a boundless curiosity paired with a passion for connecting disparate ideas. “One minute in my everyday work, I can be thinking about medical physics. The other minute, I'm thinking about a surgical application or talking to a surgeon,” he explained. This ability to explore, connect, and apply knowledge across domains has fueled his success at nView medical and beyond.Cristian shared a deeply personal story about his twin sons, who were born prematurely. When one faced worsening health issues, Cristian's curiosity and persistence led to a breakthrough. By asking the right questions and engaging with clinicians, he realized his son's diagnosis was incorrect. This discovery shifted the treatment plan, ultimately saving his son's life. The experience underscored Cristian's belief in the power of curiosity and dialogue to solve complex problems.Tips for Developing This Superpower:Ask Questions: Never hesitate to ask questions, even in unfamiliar or intimidating situations.Engage with Experts: Sit down with people in different fields to learn about their work and challenges.Embrace Failure: Don't fear asking “silly” questions—curiosity often leads to unexpected insights.Leave Your Comfort Zone: Step beyond your area of expertise to explore new ideas and perspectives.Be Persistent: Keep seeking answers and connections until you find solutions.By following Cristian's example and advice, you can make curiosity and passion a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileCristian Atria (he/him):Founder & CEO, nView medicalAbout nView medical: nView medical is a Delaware, with headquarters in Salt Lake City, Utah. It is a medical technology company specializing in real-time 3D imaging solutions for spine, orthopedic, and surgical applications. By integrating advanced imaging hardware and AI-powered software, nView medical aims to enhance surgical accuracy, optimize workflows, and improve patient outcomes. The company's main product, the FDA-cleared nView s1 system, provides hospitals with an innovative imaging solution to help surgeons perform surgeries more accurately, while reducing the amount of radiation needed for imaging. Currently, nView medical is commercializing specifically in the market of pediatric spine and orthopedic surgery and has top pediatric hospitals as customers.Website: nviewmed.comX/Twitter Handle: @nviewmedical Company Facebook Page: facebook.com/profile.php?id=61575887188366Other URL: startengine.com/offering/nviewmedicalBiographical Information: A healthcare entrepreneur with over 20 years of experience in product development and commercialization. Previously at GE Healthcare, he led major platform launches. Cristian holds multiple patents and advanced degrees in engineering and business. Cristian Atria was born in Santiago, Chile.Personal Facebook Profile: facebook.com/cristian.atria.professionalInstagram Handle: @thedopple Linkedin: linkedin.com/in/catriacSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, Rancho Affordable Housing (Proactive), and Emerald PH. Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear |  Matthew Mead, Hempitecture |  Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on August 19, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, August 20, 2025, at 12:00 PM Eastern. Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on "Your Portal, Your Future: How to Choose the Right Reg CF Platform." With so many investment crowdfunding portals available today, selecting the right one can be overwhelming for both founders and investors. In this session, Devin will break down the critical factors to consider—such as platform fees, audience demographics, compliance support, industry focus, and overall user experience. Whether you're a founder planning a raise or an investor exploring where to put your dollars to work, you'll walk away with a clearer understanding of how to evaluate and choose the platform that best aligns with your goals. Don't miss this practical, insight-packed hour designed to help you take your next step in the Reg CF ecosystem with confidence.SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Apply for the Live Pitch here. VIPs get access to our better-than-in-person networking, including backstage passes, VIP networking and an exclusive VIP webinar! Get your VIP access for just $25. A select group of affordable sponsorship opportunities is still available. Learn more here.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern.Future Forward Summit: San Francisco, Wednesday, June 25 · 3:30 - 8:30 pm PDT.Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Impact Accelerator Summit is a live in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

A set of AI use cases within the medical space. David Meier, Asit Sharma, and Roland Rott discuss: The latest on GE Healthcare, of which GE Healthcare Imaging is a piece. How AI is used to create efficiency gains, AND How AI is used to boost patient outcomes. Hosts: David Meier and Asit Sharma Guest: Roland Rott Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Lauren Kim is joined by Parminder Bhatia, Chief AI Officer, and Roland Rott, President and CEO of GE HealthCare Imaging, to explore how artificial intelligence is reshaping medical imaging. They discuss the potential of AI to improve efficiency, enhance diagnostic accuracy, and address key challenges like workforce shortages and rising demand for care.  This episode is sponsored by GE HealthCare. 

The Trump administration's federal cuts that have gutted grants threaten the work of Illinois researchers. Crain's contributor Judith Crown talks with host Amy Guth about the potential long-term impacts of such funding cuts.Plus: Gov. Pritzker to announce he's running for a third term; Ronald McDonald House buys neighboring Streeterville property and eyes expansion; GE HealthCare and Stanford Medicine renew partnership to push total body scanning tech; and McDonald's and Krispy Kreme end partnership over cost issues.

On this industry-sponsored episode, host Praveen Ranganath, MD continues the "Building a Cardiac CT Program" series through a conversation with David Furman, MD the cardiothoracic imaging division director at St. Lukes University Health Network in Pennsylvania. Topics include platforming CT upgrades, complex imaging reimbursement landscapes, and the halo effect of cardiac CT. Tune in and enjoy!This episode is sponsored by GE Healthcare.References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

Shannon Watts is the founder of Moms Demand Action, a prominent grassroots organization fighting gun violence in the United States. She initially aspired to be an investigative journalist, and she earned a journalism degree but transitioned into a career in public relations, spending nearly two decades in corporate communications at companies like Anthem and GE Healthcare. After taking a step back from her career to become a stay-at-home mom, the Sandy Hook tragedy in 2012 spurred her into action, and she founded Moms Demand Action with a simple Facebook group. Leveraging her communications and branding expertise, she transformed the group into a powerful nationwide movement, now part of Everytown for Gun Safety, the largest gun violence prevention organization in the country, with nearly 11 million supporters. She has since been recognized as one of Time's 100 Most Influential People and a Forbes 50 Over 50 Changemaker. She's also authored books including Fight Like a Mother and Fired Up.Buy Shannon's new book here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of The Medical Alley Podcast, we welcome Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE HealthCare. With a combination of clinical insight and technology experience, Dr. Kass-Hout has a uniquely expert perspective on AI's impact in the healthcare arena. Dr. Kass-Hout talks about how GE Healthcare is embedding AI into clinical workflows, the improvement of patient care, the reduction of clinical burden, and more. Send us a message! Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

In this episode, HR Daily Advisor Content Director Erika Randall chatted it up with Tyrese Manigault, Manager of Employee Engagement at NASCAR, at SPARK HR 2025, about creative ways to engage employees—whether they're new and onboarding or seasoned and looking for career pathways. Manigault shares how NASCAR engagement initiatives are meeting employees where they are and engaging them in a modern and creative way. Learn also about NASCAR's peer recognition program that's embedded in this top-ranked motorsports organization of the world! Did you miss SPARK HR this spring? Not to worry! Join us live in San Antonio at SPARK TALENT 2025 and get practical strategies focusing on workforce planning, talent acquisition, and AI-driven processes! Discover proven solutions from top HR thought leaders from PepsiCo, Walmart, Staples, The Coca-Cola Company, Marriott, and GE HealthCare, and get ready to adapt your talent strategy for the future.

Host Justin Barnes recorded live at HIMSS25 in Las Vegas. Stay tuned for the next few weeks to hear all his guests. This week his guest is Simon Rost, Chief Marketing Officer at GE HealthCare. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Wine, flamingos, and a glass box…this is NOT your typical BILIH episode...Amit and Jeff join you from the ASRA Spring Annual Meeting 2025 in Orlando, Florida, where they recorded live interviews with over a dozen influential thinkers in regional anesthesiology. Join us as we chat and laugh with James Kim, Sandy Kopp and Nadia Hernandez over discussions of POCUS, probe covers, catheters, the NEW anticoagulation guidelines, and much much more!

In this episode, HR Daily Advisor Content Director Erika Randall catches up with the delightful Ben Eubanks, author and Chief Research Officer at Lighthouse Research & Advisory, at SPARK HR 2025 in Disney Springs. Eubanks' research includes surveying thousands of workers each year to understand the latest workplace trends. In this podcast, Randall and Eubanks have a lively chat about Eubanks' books, the workshops he led at SPARK, and how to help HR leaders solve workplace issues using “innovation sprints.” Eubanks' books include: Artificial Intelligence for HR: Use AI to Support and Develop a Successful Workforce Talent Scarcity: How to Hire and Retain a Shrinking Workforce Payroll Promise: Trust, Not Just Transactions Did you miss SPARK HR this spring? Not to worry! Join us live in San Antonio at SPARK TALENT 2025 and get practical strategies focusing on workforce planning, talent acquisition, and AI-driven processes! Discover proven solutions from top HR thought leaders from PepsiCo, Walmart, Staples, The Coca-Cola Company, Marriott, and GE HealthCare, and get ready to adapt your talent strategy for the future.

US equity futures are pointing to a higher open today. European markets are firmer, following notable strength in Asian markets. Global markets influenced by China Commerce Ministry's remark that Beijing is evaluating the US offer on trade negotiations, which signals China's openness to discussions. The softened tone now is being seen as a latest de-escalation signal following recent reports that Beijing has quietly exempted certain US-made goods from tariffs. Japan also aims to achieve a trade agreement with the US in June, though the country has suggested that treasury holdings are among cards it may use in talks.Companies mentioned: Viper Energy, GE HealthCare, Johnson & Johnson, Medtronic, JetBlue Airways

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com GE Healthcare is leading the way in global medical technology and pharmaceutical diagnostics by leveraging innovations like AI and cloud computing to reduce healthcare disparities and improve access. In this episode of The Beat Podcast, Dr. Taha Kass-Hout, GE Healthcare's Global Chief Science and Technology Officer, discusses how GE Healthcare is leading in global medical technology and pharmaceutical diagnostics through innovations like AI and cloud computing to reduce healthcare disparities and improve access. He introduces the AI-driven CareIntellect platform for oncology and the Health Companion project, which uses agentic AI to optimize patient treatment plans. Dr. Kass-Hout also explains how these technologies can alleviate clinician burnout by streamlining workflows and enhancing operational efficiencies, and highlights GE Healthcare's AI Lab initiative focused on mammography screening. Tune in to gain valuable insights into how GE Healthcare is driving innovation and transforming the future of healthcare. Resources: Connect with and follow Dr. Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and visit their website. Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Are you ready optimize your team's performance and efficiency? In this podcast hosted by Mark Bailes, GE Healthcare Technical Product Lead Erica Ahn will be speaking on the art and science of organizational design. Drawing from her extensive experience at GE Healthcare, Erica shares insights on how to strategically structure teams, manage change, and drive business outcomes through thoughtful organizational approaches.